MedTrace Logo

GLP-1 Receptor Expression in CHI

NCT03768518 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2018-12-07

No results posted yet for this study

Summary

The primary objective is the in vivo and ex vivo investigation of the expression and distribution of the GLP-1R in the pancreas of CHI patients.

Conditions

  • Congenital Hyperinsulinism

Interventions

DIAGNOSTIC_TEST

68Ga-exendin-4 PET/CT

68Ga-exendin-4 PET/CT

Sponsors & Collaborators

  • European Commission

    collaborator OTHER

  • University College, London

    collaborator OTHER

  • Charite University, Berlin, Germany

    collaborator OTHER

  • University Hospital, Basel, Switzerland

    collaborator OTHER

  • Insel Gruppe AG, University Hospital Bern

    collaborator OTHER

  • University of Helsinki

    collaborator OTHER

  • Turku University Hospital

    collaborator OTHER_GOV

  • University Medical Center Groningen

    collaborator OTHER

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Martin Gotthardt, Prof. · Radboud University Medical Center

Eligibility

Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-07
Primary Completion
2019-02-01
Completion
2019-02-01

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03768518 on ClinicalTrials.gov